Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Successful RNA interference to turn off multiple genes raises hope for new liver disease treatments

Researchers at MIT and Alnylam Pharmaceuticals report this week that they have successfully used RNA interference to turn off multiple genes in the livers of mice, an advance that could lead to new treatments for diseases of the liver and other organs.

29 Dec 2009

Aeolus Pharmaceuticals reports financial results for three months and twelve months ended September 30, 2009

Aeolus Pharmaceuticals, Inc. announced today financial results for the three months and twelve months ended September 30, 2009. The Company reported a net loss of $746,000, or $0.02 per share, for the three months ended September 30, 2009 compared to a loss of $1,055,000, or $0.03 per share, for the three months ended September 30, 2008.

28 Dec 2009

SemBioSys Genetics' Apo AI(Milano) program progress update

SemBioSys Genetics Inc. provided an update today on its progress on plant-produced Apo AI(Milano) in light of the Apo AI(Milano) license agreement between Pfizer Inc. and The Medicines Company, of Parsippany, New Jersey.

24 Dec 2009

Increase in COBRA health care plan enrollment rates among subsidy-eligible employees

A new analysis from Hewitt Associates, a global human resources consulting and outsourcing company, indicates that average monthly enrollment rates in COBRA health care plans among subsidy-eligible employees have increased by 20 percentage points since the COBRA subsidy was enacted in March 2009.

24 Dec 2009

Teva-KOWA Pharma signs definitive agreement to acquire major shares in Taisho Pharmaceutical Industries

Teva Pharmaceutical Industries Ltd. announced today that Teva-KOWA Pharma Co., Ltd., the Company's joint venture in Japan with KOWA Company, Ltd., has signed a definitive agreement to acquire a majority of the outstanding shares of Taisho Pharmaceutical Industries, Ltd.

24 Dec 2009

Drug companies winners of the American prescription drug debate

On Dec. 15, the Obama Administration rejected a plan to allow the wholesale reimportation of cheaper prescriptions drugs from abroad, despite projected intentions to take on the drug industry and secure cheaper prescription for Americans.

24 Dec 2009

MiMedx Group launches its Paradis Vaso Shield vessel cover product

MiMedx Group, Inc. announced today that it has officially launched its first product, Paradis Vaso Shield(TM). In April 2009, The Food and Drug Administration cleared the Vaso Shield for use as a cover for vessels following anterior vertebral surgeries. The Vaso Shield is a permanent and transparent hydrogel product protected by multiple patents and patent applications, as well as a proprietary manufacturing process.

24 Dec 2009

Elusys Therapeutics receives contract to speed up drug development for Anthrax

The HHS Biomedical Advanced Research and Development Authority (BARDA) today awarded a contract to Elusys Therapeutics, Inc. of Pine Brook, N.J., for the advanced development of a medication to treat inhalational anthrax, one of the top bioterrorism threats facing the nation.

23 Dec 2009

Volcano lauds revised guidelines for treating severe coronary artery disease patients

Volcano Corporation, a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, reacted positively to the new guidelines for treating coronary disease and heart attacks using percutaneous coronary intervention (PCI), a procedure that treats narrowed blood vessels.

23 Dec 2009

BioLife Solutions receives ISO 13485:2003 certification

BioLife Solutions, Inc., a leading developer, manufacturer, and marketer of biopreservation tools for cells, tissues, and organs, today announced that it has successfully completed audits of its quality systems and GMP production facility in Bothell, Washington by BSI Group and has been issued a certification to ISO 13485:2003, an international standard for quality systems supporting the design, development, and manufacture of medical devices.

23 Dec 2009

Mediware Information Systems introduces new system interface to the U.S. Biovigilance Network

Continuing its diligent focus on patient safety, Mediware Information Systems, Inc. has announced the availability of a new system interface that will enable customers using the Company's LifeTrak® blood donor management software to electronically transmit blood donation data to the U.S. Biovigilance Network.

23 Dec 2009

RPC declares 2010 business plans

Radient Pharmaceuticals Corporation, a US-based vertically integrated pharmaceutical company, whose wholly-owned subsidiary AMDL Diagnostics, Inc. (ADI) announced today it 2010 Business Plan. This forecast is based upon the Company raising at least $2 million during the first half of 2010.

23 Dec 2009

Smith & Nephew acquires property, manufacturing and operation assets of Nucryst Pharmaceuticals

The Advanced Wound Management division of Smith & Nephew plc (LSE: SN; NYSE: SNN), announced today that its affiliates have completed the acquisition of substantially all of the assets of Nucryst Pharmaceuticals Corp. ("Nucryst").

22 Dec 2009

Matrix Laboratories receives FDA tentative approval for Efavirenz NDA under PEPFAR

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Efavirenz Tablets, 50 mg, 100 mg and 200 mg. These innovative pediatric dosages in tablet form were developed by Matrix for use in treating pediatric HIV/AIDS.

22 Dec 2009

Derma Sciences receives licensing rights to wound and skin care products

Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a specialty medical device and pharmaceutical company focused on advanced wound care, today announced that it has completed a comprehensive Heads of Agreement with Comvita New Zealand Ltd. (Comvita) of Paengaroa, New Zealand, covering the worldwide licensing rights for MEDIHONEY® professional wound care and skin care products.

22 Dec 2009

QLT Ophthalmics to distribute Visudyne in the U.S. market

QLT Inc. ("QLT" or the "Company") is pleased to announce the establishment of its commercial presence in the United States through a newly formed U.S. subsidiary, QLT Ophthalmics, Inc. ("QOI"). QOI will take on the sales and marketing of Visudyne(R) in the U.S.

22 Dec 2009

Shire submits REPLAGAL BLA with the FDA

Shire plc , the global specialty biopharmaceutical company, today announced that it has submitted a BLA with the FDA for REPLAGAL(R) (agalsidase alfa), its enzyme replacement therapy for Fabry disease. REPLAGAL first received marketing authorization in the European Union in 2001, and is approved for the treatment of Fabry disease in 45 countries.

22 Dec 2009

Cell Medica receives second grant for development of adenovirus infection therapy

Cell Medica, a clinical stage cellular therapeutics company engaged in the development and delivery of cellular immunotherapy treatment strategies for infectious disease and cancer, has announced that is has appointed four key staff to drive forwards the Company’s activities in the commercialisation of cell therapy treatments.

22 Dec 2009

Study results of CSL’s pandemic H1N1 2009 vaccine published in JAMA

CSL Limited, Australia’s leading biopharmaceutical company, announced the Journal of the American Medical Association (JAMA) has published data from a clinical trial conducted in Australia to study CSL’s pandemic H1N1 2009 ‘swine’ flu vaccine.

22 Dec 2009

Avery Dennison Specialty Tape's ultra-thin hydrocolloid adhesives deliver real consumer benefits

Avery Dennison Specialty Tape has developed a proprietary adhesive technology that adds significant value to consumer wound care products. Its newest generation of ultra-thin hydrocolloid adhesives delivers real consumer benefits in terms of better wear comfort, flexibility, longer wear time, less skin softening beneath the dressing, and gentle removal.

22 Dec 2009

Manufacturing News and Research

Further Reading

Successful RNA interference to turn off multiple genes raises hope for new liver disease treatments

Aeolus Pharmaceuticals reports financial results for three months and twelve months ended September 30, 2009

SemBioSys Genetics' Apo AI(Milano) program progress update

Increase in COBRA health care plan enrollment rates among subsidy-eligible employees

Teva-KOWA Pharma signs definitive agreement to acquire major shares in Taisho Pharmaceutical Industries

Drug companies winners of the American prescription drug debate

MiMedx Group launches its Paradis Vaso Shield vessel cover product

Elusys Therapeutics receives contract to speed up drug development for Anthrax

Volcano lauds revised guidelines for treating severe coronary artery disease patients

BioLife Solutions receives ISO 13485:2003 certification

Mediware Information Systems introduces new system interface to the U.S. Biovigilance Network

RPC declares 2010 business plans

Smith & Nephew acquires property, manufacturing and operation assets of Nucryst Pharmaceuticals

Matrix Laboratories receives FDA tentative approval for Efavirenz NDA under PEPFAR

Derma Sciences receives licensing rights to wound and skin care products

QLT Ophthalmics to distribute Visudyne in the U.S. market

Shire submits REPLAGAL BLA with the FDA

Cell Medica receives second grant for development of adenovirus infection therapy

Study results of CSL’s pandemic H1N1 2009 vaccine published in JAMA

Avery Dennison Specialty Tape's ultra-thin hydrocolloid adhesives deliver real consumer benefits

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News